Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases

British Journal of Cancer

Volumn 103, Issue 2, 2010, Pages 159-164

  Mekenkamp, L J M ^a   Koopman, M ^b   Teerenstra, S ^a   Van Krieken, J H J M ^a   Mol, L ^c   Nagtegaal, I D ^a   Punt, C J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Integraal Kankercentrum Oost   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; IRINOTECAN; LACTATE DEHYDROGENASE; OXALIPLATIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METACHRONOUS METASTASIS; METASTASIS; MUCINOUS CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SYNCHRONOUS METASTASIS; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION;

ADULT; AGED; CLINICAL TRIALS, PHASE III AS TOPIC; COLORECTAL NEOPLASMS; FEMALE; HUMANS; HYDRO-LYASES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954659502     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605737     Document Type: Article

References (0)